To assess predisposing factors in patients of mucormycosis following COVID infection at a tertiary hospital in North India
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B463- Cutaneous mucormycosisHealth Condition 3: B464- Disseminated mucormycosisHealth Condition 4: B465- Mucormycosis, unspecifiedHealth Condition 5: B461- Rhinocerebral mucormycosis
- Registration Number
- CTRI/2021/10/037466
- Lead Sponsor
- ITIKA BERI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 94
Inclusion Criteria
Patients with Mucormycosis admitted at the tertiary care center
Exclusion Criteria
Patients without Mucormycosis admitted at the hospital and patients who do not give consent to be a part of the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess predisposing factors for MucormycosisTimepoint: At baseline
- Secondary Outcome Measures
Name Time Method Association of severity of disease with predisposing factors.Timepoint: At baseline